<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43D5B366-CC13-4795-A805-37D9E9DF5588"><gtr:id>43D5B366-CC13-4795-A805-37D9E9DF5588</gtr:id><gtr:name>Howard Hughes Medical Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Clinical and Experimental Medicine</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43D5B366-CC13-4795-A805-37D9E9DF5588"><gtr:id>43D5B366-CC13-4795-A805-37D9E9DF5588</gtr:id><gtr:name>Howard Hughes Medical Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/49E7A3A0-05EB-419E-ADE6-CE97355D2F28"><gtr:id>49E7A3A0-05EB-419E-ADE6-CE97355D2F28</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Barratt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/913C336F-DB63-4CDB-BB47-4EA54904AB6D"><gtr:id>913C336F-DB63-4CDB-BB47-4EA54904AB6D</gtr:id><gtr:firstName>Bryan</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16"><gtr:id>1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Patricia</gtr:otherNames><gtr:surname>O'Neill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3299E160-8FED-4481-889C-5656127196F3"><gtr:id>3299E160-8FED-4481-889C-5656127196F3</gtr:id><gtr:firstName>Martyn</gtr:firstName><gtr:surname>Bell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300332"><gtr:id>8008B974-01E7-4738-AED2-8CCCB913227E</gtr:id><gtr:title>Epigenetics of heterochromatin formation and gene silencing in human embryonic stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300332</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>242640</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Howard Hughes Medical Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dosage compensation in embryonic stem cells</gtr:description><gtr:id>D8695F50-F86D-45D6-AD9D-ADFEB4BE08CA</gtr:id><gtr:impact>PM 18076287</gtr:impact><gtr:outcomeId>65244DC105E-2</gtr:outcomeId><gtr:partnerContribution>Supply of hybrid, mutant ES cell lines, advice and discussionSupply of hybrid, mutant ES cell lines, advice and discussion</gtr:partnerContribution><gtr:piContribution>Microarray analyses of gene expression in hybrid, mutant ES cell lines</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Crosstalk amongst histone modifications</gtr:description><gtr:id>A6B9AF8C-B7CA-42D3-94C9-4F25D587DBAD</gtr:id><gtr:impact>PM 17166833</gtr:impact><gtr:outcomeId>4D39599D138-1</gtr:outcomeId><gtr:partnerContribution>In vitro assay of histone methyltransferase (SET domain) activity against modified peptide substrates</gtr:partnerContribution><gtr:piContribution>Analysis of histone methylation in response to deacetylase inhibitors</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dosage compensation in embryonic stem cells</gtr:description><gtr:id>0CC765B7-6227-41CF-AB94-84D1F4300D70</gtr:id><gtr:impact>PM 18076287</gtr:impact><gtr:outcomeId>65244DC105E-1</gtr:outcomeId><gtr:partnerContribution>Supply of hybrid, mutant ES cell lines, advice and discussionSupply of hybrid, mutant ES cell lines, advice and discussion</gtr:partnerContribution><gtr:piContribution>Microarray analyses of gene expression in hybrid, mutant ES cell lines</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NoE booklet</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9A04115-68D5-41DE-9F2A-F1E487834820</gtr:id><gtr:impact>Contributed through interviews to a widely distributed booklet on epigenetics for a lay audience (also on line)

Develpment of further outreach activities organised through the Epigenome Network</gtr:impact><gtr:outcomeId>34480A89449</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>Pre-2006,2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>19970DF1-7E62-4EDE-923D-50B7144BE7A5</gtr:id><gtr:impact>Dr Laura O'Neill lectured to year 6 primary school pupils on biomedical research three times a year

Improved awareness of the importance of scientific research among young children</gtr:impact><gtr:outcomeId>3E2A89F3527</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Microarray exrpession data from male and female mouse embryonic stem cells differentiating in culture.</gtr:description><gtr:id>7176AF7C-6511-4F5F-95F2-C02811621715</gtr:id><gtr:impact>publication PM 18076287</gtr:impact><gtr:outcomeId>802BCBF98DF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray gene expression data</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18076289</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F931F591-F201-4402-B5AA-97581B889B4F</gtr:id><gtr:title>Open chromatin and hypertranscription in embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/294870139ec438296c3c3e894ff001fb"><gtr:id>294870139ec438296c3c3e894ff001fb</gtr:id><gtr:otherNames>Turner BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>8A510ED41D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6911979-20FB-4376-B0DB-F026EE09690D</gtr:id><gtr:title>Dosage compensation in the mouse balances up-regulation and silencing of X-linked genes.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fcbe089751d63ca9d3cd02742981ed6"><gtr:id>6fcbe089751d63ca9d3cd02742981ed6</gtr:id><gtr:otherNames>Lin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>3DFC4C01510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C98D11F4-3BC1-44EF-BBB9-E28FB92EEA76</gtr:id><gtr:title>Histone modifications: signalling receptors and potential elements of a heritable epigenetic code.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6384ff12c397150905a4b6617716b2f3"><gtr:id>6384ff12c397150905a4b6617716b2f3</gtr:id><gtr:otherNames>Nightingale KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>6D14C9B5B2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29D0A584-2D3D-4166-B317-0C305FA2AB95</gtr:id><gtr:title>Defining an epigenetic code.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/294870139ec438296c3c3e894ff001fb"><gtr:id>294870139ec438296c3c3e894ff001fb</gtr:id><gtr:otherNames>Turner BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>A3DFFD747C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>813DC5C5-92D4-4C66-831F-57011BA89CB8</gtr:id><gtr:title>Relative overexpression of X-linked genes in mouse embryonic stem cells is consistent with Ohno's hypothesis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fcbe089751d63ca9d3cd02742981ed6"><gtr:id>6fcbe089751d63ca9d3cd02742981ed6</gtr:id><gtr:otherNames>Lin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16525_25_22120049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>652F3718-62F7-45E9-9EC9-F77BB8F5D348</gtr:id><gtr:title>Differential loss of histone H3 isoforms mono-, di- and tri-methylated at lysine 4 during X-inactivation in female embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d6585713f374450dc23993932c76cb"><gtr:id>c2d6585713f374450dc23993932c76cb</gtr:id><gtr:otherNames>O'Neill LP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1431-6730</gtr:issn><gtr:outcomeId>F794D4E8AED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A9CC1D8-2047-426A-8E88-12D47FA5D506</gtr:id><gtr:title>Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6384ff12c397150905a4b6617716b2f3"><gtr:id>6384ff12c397150905a4b6617716b2f3</gtr:id><gtr:otherNames>Nightingale KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>590FD6E991F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300332</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>